Rafferty Asset Management, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 364 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,831,534
+0.1%
231,192
-5.5%
0.05%
+4.0%
Q2 2023$8,820,738
+41.3%
244,545
+49.6%
0.05%
+19.0%
Q1 2023$6,241,888
-22.5%
163,443
+15.4%
0.04%
-37.3%
Q4 2022$8,057,211
+21.8%
141,603
-15.4%
0.07%
-4.3%
Q3 2022$6,615,000
+72.5%
167,295
+92.0%
0.07%
+100.0%
Q2 2022$3,835,000
-37.6%
87,152
-43.4%
0.04%
-2.8%
Q1 2022$6,141,000
-0.1%
153,996
+0.8%
0.04%
+12.5%
Q4 2021$6,146,000
+99.9%
152,843
+102.3%
0.03%
+52.4%
Q3 2021$3,074,000
+11.1%
75,556
+23.9%
0.02%
+23.5%
Q2 2021$2,768,000
-11.6%
60,964
-18.8%
0.02%
-19.0%
Q1 2021$3,130,000
+222.7%
75,086
+230.6%
0.02%
+133.3%
Q4 2020$970,000
-49.7%
22,710
-69.0%
0.01%
-60.9%
Q3 2020$1,928,000
+71.8%
73,351
+75.3%
0.02%
+43.8%
Q2 2020$1,122,000
-22.4%
41,845
-48.7%
0.02%
-27.3%
Q4 2019$1,446,000
-40.5%
81,544
-47.9%
0.02%
-42.1%
Q3 2019$2,429,000
+4.5%
156,578
+15.7%
0.04%
-7.3%
Q2 2019$2,325,000
+36.8%
135,307
+28.2%
0.04%
+51.9%
Q1 2019$1,699,000105,5490.03%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Third Security, LLC 7,048,282$126,799,00027.23%
First Light Asset Management, LLC 1,630,591$29,334,0005.01%
SNYDER CAPITAL MANAGEMENT L P 3,393,057$61,041,0003.48%
Bellevue Group AG 7,663,956$137,874,0002.67%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 307,633$5,531,0002.52%
Lombard Odier Asset Management (Switzerland) SA 900,000$16,191,0002.17%
Elk Creek Partners, LLC 654,362$11,772,0002.02%
DOHENY ASSET MANAGEMENT /CA 127,110$2,254,0001.79%
Granite Investment Partners, LLC 1,277,438$22,981,0001.49%
Amia Capital LLP 69,409$1,249,0001.11%
View complete list of HALOZYME THERAPEUTICS INC shareholders